Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.6.2023Fresenius Kabi s.r.o. (FRK-CZ-3)37752Sodium chloride Fresenius Kabi 0,9 % (sol inf 20x250 ml (fľ.LDPE - KabiPac))22.6.2023O
 20.6.2023Fresenius Kabi s.r.o. (FRK-CZ-3)1551CBenelyte (sol inf 20x250 ml (fľ.LDPE))21.6.2023O
 20.6.2023Fresenius Kabi Austria GmbH (FRK-A)87596Kalium-L-malat Fresenius 1 molar (con inf 20x20 ml (amp.PP))22.6.2023O
 20.6.2023Egis Pharmaceuticals PLC (EGI)6891BRasagiline Egis 1 mg tablety (tbl 30x1 mg (blis.Al/Al))23.6.2023R
 19.6.2023Vipharm S.A. (VIH-PL-1)8189AMemantine Vipharm 20 mg (tbl flm 98x20 mg (blis.PVC/Al))16.6.2023O
 19.6.2023Vipharm S.A. (VIH-PL-1)8182AMemantine Vipharm 20 mg (tbl flm 28x20 mg (blis.PVC/Al))16.6.2023O
 19.6.2023Vipharm S.A. (VIH-PL-1)6810CAnagrelide Vipharm 0,5 mg (cps dur 100x0,5 mg (fľ.HDPE))16.6.2023O
 19.6.2023Vipharm S.A. (VIH-PL-1)47803Donesyn 10 mg (tbl flm 98x10 mg (blis.PVC/Al))16.6.2023O
 19.6.2023XANTIS PHARMA LIMITED (XNT-1)7477ATelmisartan/Hydrochlorotiazid Xantis 80 mg/12,5 mg (tbl 28x80 mg/12,5 mg(blis.Al/Al))19.6.2023R
 19.6.2023BIOMEDICA spol. s r.o. (BCS)01063FRAMYKOIN (plv ads 1x20 g (nád.PE))1.7.2023O
 19.6.2023BIOMEDICA spol. s r.o. (BCS)67133BIOTUSSIL (gtt por 1x100 ml (liek.skl.hnedá))1.7.2023R
 19.6.2023Egis Pharmaceuticals PLC (EGI)14759Telviran 5 % (crm 1x2 g (tuba Al))18.2.2023Z
 19.6.2023MEDOCHEMIE Ltd. (MOE)39638ALMIRAL GEL (gel 1x100 g (tuba Al))16.6.2023R
 19.6.2023MEDOCHEMIE Ltd. (MOE)5243BAXETINE 500 mg (tbl flm 10x500 mg (blis.Al/Al))16.6.2023R
 17.6.2023STADA Arzneimittel AG (STD)6242DLevetiracetam STADA Arzneimittel 250 mg filmom obalené tablety (tbl flm 50x250 mg (blis.Al/PVC/PE/PVDC))14.6.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)